Innovative Molecular Analysis Technology (IMAT) Development for Cancer Research and Clinical Care
Next due date: May 27, 2015
The SBIR-IMAT solicitation will provide small businesses the opportunity to advance technologies that improve molecular and/or cellular analysis of cancer with a significant likelihood for either overcoming persistent challenges or obstacles or opening entirely new fields for cancer research or clinical care. View resources from the latest webinar on SBIR-IMAT.
View the full SBIR-IMAT FOA: PAR-13-327, Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (R43/R44)